“…These compounds are well known for their effects on cholesterol blood levels (Wong, 2014); however, research into their potential role in mitigating cancer risk, and specifically colon cancer, has received comparably little attention (Bradford & Awad, 2010;Grattan, 2013). It has been reported that β-sitosterol, the prevalent Ps in the diet, has antiproliferative effects in rat models of colon cancer (Awad, Tagle-Hernandez, Fink, & Mendel, 1997;Baskar et al, 2012;Baskar, Ignacimuthu, Paulraj, & Al Numair, 2010;Raitch, Cohen, Faqzzani, Sarwal, & Takahashi, 1980) and in the colon cancer cell lines HT-29, HCT116 and Colo 320, within the range of physiological plasma concentrations (4-70 µM) (Awad, Chen, Fink, & Hennessey, 1996;Awad & Fink, 2000;Choi et al, 2003;Jayaprakasha, Jadegoud, Nagana Gowda, & Patil, 2010;Montserrat-de la Paz, Fernández-Arche, Bermúdez, & García-Giménez, 2015). In other cases, inhibition of colon cancer cell growth (Caco-2 cells) has been observed with pharmacological levels of β-sitosterol and campesterol (≥100 µM) (Daly, Aherne, O'Connor, & O'Brien, 2009).…”